Loading…
Dividends declared (per SOCE filings): FY2023 0 · FY2024 87 — 2-yr total 87
Shotapharm LLC is a Tbilisi-based pharmaceutical company operating in the Gldani / Tbilisi Technology Park free industrial zone, engaged in pharmaceutical manufacturing and distribution alongside other Turkish-linked pharma investments in Georgia.
| Line item | 2023 | 2024 | CAGR |
|---|---|---|---|
| Total Revenue | 127,232 | 327,423 | +157.3% |
| Total COGS | 78,842 | 164,945 | +109.2% |
| Gross Profit | 48,390 | 162,478 | +235.8% |
| Gross Margin | 38.0% | 49.6% | |
| 1,498 | 5,564 | +271.4% | |
| EBITDA | 46,892 | 156,914 | +234.6% |
| EBITDA Margin | 36.9% | 47.9% | |
| Total D&A | 0 | 0 | |
| EBIT / Operating Income | 46,892 | 156,914 | +234.6% |
| Profit Before Tax | 46,892 | 156,914 | +234.6% |
| Total Income Tax | 0 | 0 | |
| Net Profit / (Loss) | 46,892 | 156,914 | +234.6% |
| Net Margin | 36.9% | 47.9% | |
| Other Comprehensive Income | 1,186 | 7,060 | +495.3% |
| Total Comprehensive Income | 48,078 | 163,974 | +241.1% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →